Opakalim, a Kv7.2/7.3 potassium channel activator, was used compassionately to treat a child with KCNQ2 developmental and epileptic encephalopathy.
Absolute Event Rate: 0% vs 0%
Describe a case report of KCNQ2-DEE treated with opakalim.
Olson et al. (Tue,) reported a other. Opakalim, a Kv7.2/7.3 potassium channel activator, was used compassionately to treat a child with KCNQ2 developmental and epileptic encephalopathy.